Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. X:X | DOI: 10.5507/bp.2026.016

Successful transcranial motor evoked potentials monitoring under remimazolam-based anaesthesia: Case reports of two patients

Jan Hudec1, 2, Tereza Prokopova1, 2, Michal Galko3, Roman Gal1
1 Department of Anaesthesiology and Intensive Care Medicine, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic
2 Department of Simulation Medicine, Faculty of Medicine, Masaryk University, Brno, Czech Republic
3 Department of Orthopaedic and Spine Surgery, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic

Introduction: Intraoperative neurophysiological monitoring is a standard in surgeries with an increased risk of iatrogenic neurological injury development. The gold standard for this monitoring modality is propofol-based total intravenous anaesthesia (TIVA). Although there seems to be no clinically significant complication for propofol administration in patients with soy, egg, or peanut allergies, a whole range of recommendations still prohibit propofol administration in patients with these allergies. Remimazolam is a new, ultra-short-acting benzodiazepine that can potentially be an alternative in cases of propofol contraindications in need of TIVA.

Case reports: We report two cases of a 19-year-old girl and a 17-year-old boy undergoing scoliosis surgery with transcranial motor evoked potentials monitoring (TcMEP). We chose remimazolam-based total intravenous anaesthesia due to the severe peanut and soy allergy, respectively. Total intravenous anaesthesia was maintained with remimazolam at a dose of 1.5-2 mg/kg/h and remifentanil at a dose of 0.5-0.8 µg/kg/min. Depth of anaesthesia was controlled using frontal EEG monitoring. TcMEP remained stable and showed no significant alterations throughout the surgeries. No new neurological deficits were detected after the surgeries.

Conclusion: Our results show that remimazolam-based anaesthesia may be a safe alternative to propofol-based anaesthesia for surgeries with an intraoperative neurophysiological monitoring, or patients with propofol contraindications but more data are needed.

Keywords: total intravenous anaesthesia, remimazolam, scoliosis, motor evoked potentials, case report

Received: January 26, 2026; Revised: May 22, 2026; Accepted: June 15, 2026; Prepublished online: July 7, 2026 

Download citation

References

  1. Strike SA, Hassanzadeh H, Jain A, Kebaish KM, Njoku DB, Becker D, Ain MC, Sponseller PD. Intraoperative Neuromonitoring in Pediatric and Adult Spine Deformity Surgery. Clin Spine Surg 2017;30(9):E1174-E1181. Go to original source...
  2. Halsey MF, Myung KS, Ghag A, Vitale MG, Newton PO, de Kleuver M. Neurophysiological monitoring of spinal cord function during spinal deformity surgery: 2020 SRS neuromonitoring information statement. Spine Deform 2020;8(4):591-6. Go to original source...
  3. Sahinovic MM, Gadella MC, Shils J, Dulfer SE, Drost G. Anesthesia and intraoperative neurophysiological spinal cord monitoring. Curr Opin Anaesthesiol 2021;34(5):590-6. Go to original source...
  4. Lotto ML, Banoub M, Schubert A. Effects of anesthetic agents and physiologic changes on intraoperative motor evoked potentials. J Neurosurg Anesthesiol 2004;16(1):32-42. Go to original source...
  5. Asserhøj LL, Mosbech H, Krøigaard M, Garvey LH. No evidence for contraindications to the use of propofol in adults allergic to egg, soy or peanut. Br J Anaesth 2016;116(1):77-82. Go to original source...
  6. Adler AC. Propofol: Review of Potential Risks During Administration. AANA J 2017;85(2):104-7.
  7. Cochico SG. Propofol allergy: assessing for patient risks. AORN J 2012;96(4):398-405. Go to original source...
  8. Harper NJ. Propofol and food allergy. Br J Anaesth 2016;116(1):11-13. Go to original source...
  9. Hudec J, Kosinova M, Horak O, Repko M, Gal R. Challenging anesthesia of the patient on ketogenic diet therapy scheduled for scoliosis surgery under motor evoked potentials monitoring: a case report. J Anesth 2023;37(5):815-17. Go to original source...
  10. Masui K. Remimazolam besilate, a benzodiazepine, has been approved for general anesthesia!! J Anesth 2020;34(4):47-482. Go to original source...
  11. de Jong BT, Eleveld DJ, Mason KP, Struys MMRF. Clinical Pharmacokinetics and Pharmacodynamics of Remimazolam. Clin Pharmacokinet 2025;64(9):1263-82. Go to original source...
  12. Teixeira MT, Goyal A. Remimazolam. Adv Anesth 2024;42(1):131-50. Go to original source...
  13. Kamata K, Asagi S, Shimoda Y, Kanamori M, Abe N, Sugino S, Tominaga T, Yamauchi M. Successful recording of direct cortical motor-evoked potential from a pediatric patient under remimazolam anesthesia: a case report. JA Clin Rep 2022;8(1):66. Go to original source...
  14. Kimura Y, Hashimoto S, Yamakage M, Mikuni N. The intraoperative motor-evoked potential when propofol was changed to remimazolam during general anesthesia: a case series. J Anesth 2023;37(1):154-9. Go to original source...
  15. Arashiro A, Shinzato H, Kamizato K, Kakinohana M. Spinal fusion with motor evoked potential monitoring using remimazolam in Alström syndrome: A case report. Medicine (Baltimore) 2021;100(47):e27990. Go to original source...
  16. Pieri M, D'Andria Ursoleo J, Di Prima AL, Bugo S, Barucco G, Licheri M, Losiggio R, Frau G, Monaco F; Collaborators. Remimazolam for anesthesia and sedation in pediatric patients: a scoping review. J Anest 2024;38(5):692-710. Go to original source...
  17. Kim KM. Remimazolam: pharmacological characteristics and clinical applications in anesthesiology. Anesth Pain Med (Seoul) 2022;17(1):1-11. Go to original source...
  18. Penninga EI, Graudal N, Ladekarl MB, Jürgens G. Adverse Events Associated with Flumazenil Treatment for the Management of Suspected Benzodiazepine Intoxication--A Systematic Review with Meta-Analyses of Randomised Trials. Basic Clin Pharmacol Toxicol 2016;118(1):37-44. Go to original source...
  19. Wu X, Wang C, Gao H, Bai X, Zhang Z, Chen R, Huang X, An L, Yi J, Tong R. Comparison of remimazolam and propofol about safety outcome indicators during general anesthesia in surgical patients: a systematic review and meta-analysis. Minerva Anestesiol 2023;89(6):553-64. Go to original source...
  20. Ko CC, Hung KC, Illias AM, Chiu CC, Yu CH, Lin CM, Chen IW, Sun CK. The use of remimazolam versus propofol for induction and maintenance of general anesthesia: A systematic review and meta-analysis. Front Pharmacol 2023;14:1101728. Go to original source...
  21. Oh EJ, Chung YJ, Lee JH, Kwon EJ, Choi EA, On YK, Min JJ. Comparison of propofol vs. remimazolam on emergence profiles after general anesthesia: A randomized clinical trial. J Clin Anesth 2023;90:111223. Go to original source...
  22. Peng X, Liu C, Zhu Y, Peng L, Zhang X, Wei W, Zhu T. Hemodynamic Influences of Remimazolam Versus Propofol During the Induction Period of General Anesthesia: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Pain Physician 2023;26(7):E761-E773 Go to original source...
  23. Lee TY, Kim MA, Eom DW, Jung JW, Chung CJ, Park SY. Comparison of remimazolam-remifentanil and propofol-remifentanil during laparoscopic cholecystectomy. Anesth Pain Med (Seoul) 2023;18(3):252-9. Go to original source...
  24. Shimizu T, Takasusuki T, Yamaguchi S. Remimazolam Compared to Propofol for Total Intravenous Anesthesia with Remifentanil on the Recovery of Psychomotor Function: A Randomized Controlled Trial. Adv Ther 2023;40(10):4395-404. Go to original source...
  25. Kondo T, Toyota Y, Narasaki S, Watanabe T, Miyoshi H, Saeki N, Tsutsumi YM. Intraoperative responses of motor evoked potentials to the novel intravenous anesthetic remimazolam during spine surgery: a report of two cases. JA Clin Rep 2020;6(1):97. Go to original source...

This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.